• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPR-Cas9 介导的端粒去除导致线粒体应激和蛋白质聚集。

CRISPR-Cas9 Mediated Telomere Removal Leads to Mitochondrial Stress and Protein Aggregation.

机构信息

Division of Pharmacology, Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Samsung Biomedical Research Institute, Suwon, Gyeonggi-do 440-746, Korea.

College of Pharmacy, Chosun University, Gwangju 501-759, Korea.

出版信息

Int J Mol Sci. 2017 Oct 3;18(10):2093. doi: 10.3390/ijms18102093.

DOI:10.3390/ijms18102093
PMID:28972555
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5666775/
Abstract

Aging is considered the major risk factor for neurodegenerative diseases including Parkinson's disease (PD). Telomere shortening is associated with cellular senescence. In this regard, pharmacological or genetic inhibition of telomerase activity has been used to model cellular aging. Here, we employed CRISPR-Cas9 technology to instantly remove the telomere to induce aging in a neuroblastoma cell line. Expression of both Cas9 and guide RNA targeting telomere repeats ablated the telomere, leading to retardation of cell proliferation. Instant deletion of telomere in SH-SY5Y cells impaired mitochondrial function with diminished mitochondrial respiration and cell viability. Supporting the pathological relevance of cell aging by CRISPR-Cas9 mediated telomere removal, alterations were observed in the levels of PD-associated proteins including PTEN-induced putative kinase 1, peroxisome proliferator-activated receptor γ coactivator 1-α, nuclear respiratory factor 1, parkin, and aminoacyl tRNA synthetase complex interacting multifunctional protein 2. Significantly, α-synuclein expression in the background of telomere removal led to the enhancement of protein aggregation, suggesting positive feed-forward interaction between aging and PD pathogenesis. Collectively, our results demonstrate that CRISPR-Cas9 can be used to efficiently model cellular aging and PD.

摘要

衰老是包括帕金森病(PD)在内的神经退行性疾病的主要风险因素。端粒缩短与细胞衰老有关。在这方面,端粒酶活性的药理学或遗传学抑制已被用于模拟细胞衰老。在这里,我们使用 CRISPR-Cas9 技术即时去除端粒以诱导神经母细胞瘤细胞系衰老。表达 Cas9 和靶向端粒重复序列的指导 RNA 可消除端粒,导致细胞增殖减缓。SH-SY5Y 细胞中端粒的即时缺失损害了线粒体功能,导致线粒体呼吸和细胞活力下降。CRISPR-Cas9 介导的端粒去除导致 PD 相关蛋白水平发生变化,包括 PTEN 诱导的假定激酶 1、过氧化物酶体增殖物激活受体 γ 共激活因子 1-α、核呼吸因子 1、Parkin 和氨酰 tRNA 合成酶复合物相互作用多功能蛋白 2。值得注意的是,端粒去除背景下的 α-突触核蛋白表达导致蛋白聚集增强,表明衰老和 PD 发病机制之间存在正反馈相互作用。总之,我们的结果表明,CRISPR-Cas9 可用于有效地模拟细胞衰老和 PD。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b75/5666775/b4812eb09a51/ijms-18-02093-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b75/5666775/1f0e951b9752/ijms-18-02093-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b75/5666775/2206cc14489e/ijms-18-02093-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b75/5666775/030e8518310f/ijms-18-02093-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b75/5666775/71664605c498/ijms-18-02093-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b75/5666775/b4812eb09a51/ijms-18-02093-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b75/5666775/1f0e951b9752/ijms-18-02093-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b75/5666775/2206cc14489e/ijms-18-02093-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b75/5666775/030e8518310f/ijms-18-02093-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b75/5666775/71664605c498/ijms-18-02093-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9b75/5666775/b4812eb09a51/ijms-18-02093-g005.jpg

相似文献

1
CRISPR-Cas9 Mediated Telomere Removal Leads to Mitochondrial Stress and Protein Aggregation.CRISPR-Cas9 介导的端粒去除导致线粒体应激和蛋白质聚集。
Int J Mol Sci. 2017 Oct 3;18(10):2093. doi: 10.3390/ijms18102093.
2
Analysis of Average Telomere Length in Human Telomeric Protein Knockout Cells Generated by CRISPR/Cas9.通过CRISPR/Cas9技术生成的人类端粒蛋白敲除细胞中端粒平均长度的分析。
Methods Mol Biol. 2017;1587:15-28. doi: 10.1007/978-1-4939-6892-3_2.
3
Transcriptional mutagenesis by 8-oxodG in α-synuclein aggregation and the pathogenesis of Parkinson's disease.8-氧代脱氧鸟苷在α-突触核蛋白聚集及帕金森病发病机制中的转录诱变作用
Exp Mol Med. 2015 Aug 28;47(8):e179. doi: 10.1038/emm.2015.54.
4
Telomere shortening leads to an acceleration of synucleinopathy and impaired microglia response in a genetic mouse model.端粒缩短导致遗传小鼠模型中突触核蛋白病的加速和小胶质细胞反应受损。
Acta Neuropathol Commun. 2016 Aug 22;4(1):87. doi: 10.1186/s40478-016-0364-x.
5
Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.线粒体动力学和功能受损在帕金森病发病机制中的作用
Exp Neurol. 2009 Aug;218(2):235-46. doi: 10.1016/j.expneurol.2009.03.006. Epub 2009 Mar 18.
6
PGC-1α Modulates Telomere Function and DNA Damage in Protecting against Aging-Related Chronic Diseases.PGC-1α调节端粒功能和DNA损伤以预防与衰老相关的慢性疾病。
Cell Rep. 2015 Sep 1;12(9):1391-9. doi: 10.1016/j.celrep.2015.07.047. Epub 2015 Aug 20.
7
Targeting Telomeres and Telomerase: Studies in Aging and Disease Utilizing CRISPR/Cas9 Technology.靶向端粒和端粒酶:利用 CRISPR/Cas9 技术研究衰老和疾病。
Cells. 2019 Feb 21;8(2):186. doi: 10.3390/cells8020186.
8
Aging-associated alteration of telomere length and subtelomeric status in female patients with Parkinson's disease.帕金森病女性患者端粒长度和亚端粒状态的衰老相关改变。
J Neurogenet. 2012 Jun;26(2):245-51. doi: 10.3109/01677063.2011.651665. Epub 2012 Feb 27.
9
Efficient Mitochondrial Genome Editing by CRISPR/Cas9.利用CRISPR/Cas9进行高效的线粒体基因组编辑
Biomed Res Int. 2015;2015:305716. doi: 10.1155/2015/305716. Epub 2015 Sep 10.
10
Application of CRISPR-Cas9 Screening Technologies to Study Mitochondrial Biology in Healthy and Disease States.CRISPR-Cas9 筛选技术在健康和疾病状态下研究线粒体生物学中的应用。
Adv Exp Med Biol. 2019;1158:269-277. doi: 10.1007/978-981-13-8367-0_15.

引用本文的文献

1
Applications of CRISPR-Cas9 in mitigating cellular senescence and age-related disease progression.CRISPR-Cas9在减轻细胞衰老和与年龄相关疾病进展方面的应用。
Clin Exp Med. 2025 Jul 8;25(1):237. doi: 10.1007/s10238-025-01771-3.
2
Ultrasound Control of Genomic Regulatory Toolboxes for Cancer Immunotherapy.用于癌症免疫治疗的基因组调控工具箱的超声控制
Nat Commun. 2024 Dec 1;15(1):10444. doi: 10.1038/s41467-024-54477-7.
3
Engineered FSHD mutations results in D4Z4 heterochromatin disruption and feedforward DUX4 network activation.

本文引用的文献

1
PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival.PINK1启动Parkin介导的PARIS泛素化以促进多巴胺能神经元存活。
Cell Rep. 2017 Jan 24;18(4):918-932. doi: 10.1016/j.celrep.2016.12.090.
2
Mouse models of ageing and their relevance to disease.衰老的小鼠模型及其与疾病的关联。
Mech Ageing Dev. 2016 Dec;160:41-53. doi: 10.1016/j.mad.2016.10.001. Epub 2016 Oct 4.
3
Small molecule compounds that induce cellular senescence.诱导细胞衰老的小分子化合物。
工程化的面肩肱型肌营养不良症(FSHD)突变导致D4Z4异染色质破坏并引发DUX4网络的前馈激活。
iScience. 2024 Feb 29;27(4):109357. doi: 10.1016/j.isci.2024.109357. eCollection 2024 Apr 19.
4
Retinal Organoids: A Next-Generation Platform for High-Throughput Drug Discovery.视网膜类器官:高通量药物发现的新一代平台。
Stem Cell Rev Rep. 2024 Feb;20(2):495-508. doi: 10.1007/s12015-023-10661-8. Epub 2023 Dec 11.
5
Combining old and new concepts in targeting telomerase for cancer therapy: transient, immediate, complete and combinatory attack (TICCA).在癌症治疗中靶向端粒酶方面结合新旧概念:短暂、即时、完全和联合攻击(TICCA)。
Cancer Cell Int. 2023 Sep 7;23(1):197. doi: 10.1186/s12935-023-03041-2.
6
CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease.CRISPR/Cas9辅助干细胞疗法治疗帕金森病
Biomater Res. 2023 May 16;27(1):46. doi: 10.1186/s40824-023-00381-y.
7
LPM3770277, a Potent Novel CDK4/6 Degrader, Exerts Antitumor Effect Against Triple-Negative Breast Cancer.LPM3770277,一种新型强效CDK4/6降解剂,对三阴性乳腺癌具有抗肿瘤作用。
Front Pharmacol. 2022 Apr 11;13:853993. doi: 10.3389/fphar.2022.853993. eCollection 2022.
8
CRISPR/Cas: A New Tool in the Research of Telomeres and Telomerase as Well as a Novel Form of Cancer Therapy.CRISPR/Cas:端粒和端粒酶研究的新工具以及一种新型的癌症治疗方法。
Int J Mol Sci. 2022 Mar 10;23(6):3002. doi: 10.3390/ijms23063002.
9
Retinal Organoids and Retinal Prostheses: An Overview.视网膜类器官和视网膜假体:概述。
Int J Mol Sci. 2022 Mar 8;23(6):2922. doi: 10.3390/ijms23062922.
10
Accelerated telomere shortening independent of LRRK2 variants in Chinese patients with Parkinson's disease.帕金森病患者端粒加速缩短与 LRRK2 变异无关。
Aging (Albany NY). 2020 Oct 29;12(20):20483-20492. doi: 10.18632/aging.103878.
Aging Cell. 2016 Dec;15(6):999-1017. doi: 10.1111/acel.12518. Epub 2016 Sep 14.
4
Telomere shortening leads to an acceleration of synucleinopathy and impaired microglia response in a genetic mouse model.端粒缩短导致遗传小鼠模型中突触核蛋白病的加速和小胶质细胞反应受损。
Acta Neuropathol Commun. 2016 Aug 22;4(1):87. doi: 10.1186/s40478-016-0364-x.
5
Activation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration.酪氨酸激酶c-Abl的激活促成了α-突触核蛋白诱导的神经退行性变。
J Clin Invest. 2016 Aug 1;126(8):2970-88. doi: 10.1172/JCI85456. Epub 2016 Jun 27.
6
Rs2853677 modulates Snail1 binding to the TERT enhancer and affects lung adenocarcinoma susceptibility.Rs2853677调节Snail1与端粒酶逆转录酶(TERT)增强子的结合,并影响肺腺癌易感性。
Oncotarget. 2016 Jun 21;7(25):37825-37838. doi: 10.18632/oncotarget.9339.
7
PGC-1α Modulates Telomere Function and DNA Damage in Protecting against Aging-Related Chronic Diseases.PGC-1α调节端粒功能和DNA损伤以预防与衰老相关的慢性疾病。
Cell Rep. 2015 Sep 1;12(9):1391-9. doi: 10.1016/j.celrep.2015.07.047. Epub 2015 Aug 20.
8
The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease.PINK1、parkin 和线粒体保真度在帕金森病中的作用。
Neuron. 2015 Jan 21;85(2):257-73. doi: 10.1016/j.neuron.2014.12.007.
9
Genome editing. The new frontier of genome engineering with CRISPR-Cas9.基因组编辑。CRISPR-Cas9 技术引领的基因组工程新前沿。
Science. 2014 Nov 28;346(6213):1258096. doi: 10.1126/science.1258096.
10
Accelerating neuronal aging in in vitro model brain disorders: a focus on reactive oxygen species.体外模型脑疾病中神经元衰老的加速:聚焦活性氧
Front Aging Neurosci. 2014 Oct 27;6:292. doi: 10.3389/fnagi.2014.00292. eCollection 2014.